ANGPTL4
Angiopoietin-related protein 4
Also known as: ANGL4_HUMAN, ARP4, FIAF, HFARP, NL2, PGAR, pp1158
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BY76
- Gene
- ANGPTL4
- Ensembl
- ENSG00000167772
- Chromosome
- 19
- Canonical length
- 406 aa
- Protein class
- Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Vesicles
- Secretome location
- Secreted to blood
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes a glycosylated, secreted protein containing a C-terminal fibrinogen domain. The encoded protein is induced by peroxisome proliferation activators and functions as a serum hormone that regulates glucose homeostasis, lipid metabolism, and insulin sensitivity. This protein can also act as an apoptosis survival factor for vascular endothelial cells and can prevent metastasis by inhibiting vascular growth and tumor cell invasion. The C-terminal domain may be proteolytically-cleaved from the full-length secreted protein. Decreased expression of this gene has been associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4. [provided by RefSeq, Sep 2013]
Canonical amino-acid sequenceUniProt
406 residues, UniProt reviewed canonical sequence.
>Q9BY76|ANGPTL4
1 MSGAPTAGAA LMLCAATAVL LSAQGGPVQS KSPRFASWDE MNVLAHGLLQ LGQGLREHAE
61 RTRSQLSALE RRLSACGSAC QGTEGSTDLP LAPESRVDPE VLHSLQTQLK AQNSRIQQLF
121 HKVAQQQRHL EKQHLRIQHL QSQFGLLDHK HLDHEVAKPA RRKRLPEMAQ PVDPAHNVSR
181 LHRLPRDCQE LFQVGERQSG LFEIQPQGSP PFLVNCKMTS DGGWTVIQRR HDGSVDFNRP
241 WEAYKAGFGD PHGEFWLGLE KVHSITGDRN SRLAVQLRDW DGNAELLQFS VHLGGEDTAY
301 SLQLTAPVAG QLGATTVPPS GLSVPFSTWD QDHDLRRDKN CAKSLSGGWW FGTCSHSNLN
361 GQYFRSIPQQ RQKLKKGIFW KTWRGRYYPL QATTMLIQPM AAEAASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANGPTL4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 188 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 188 nTPM
- liver: 177 nTPM
- breast: 162 nTPM
- pancreas: 69 nTPM
- basal ganglia: 62 nTPM
- blood vessel: 58 nTPM
Single-cell type
- esophageal apical cells: 1000 nCPM
- breast lactating cells: 723 nCPM
- enterocytes: 586 nCPM
- pancreatic acinar cells: 451 nCPM
- hepatocytes: 221 nCPM
- astrocytes: 219 nCPM
Immune cell
- basophil: 3.3 nTPM
- neutrophil: 0.8 nTPM
- eosinophil: 0.4 nTPM
- NK-cell: 0.3 nTPM
- memory B-cell: 0.2 nTPM
- T-reg: 0.2 nTPM
Brain region
- midbrain: 55 nTPM
- thalamus: 48 nTPM
- white matter: 45 nTPM
- basal ganglia: 43 nTPM
- cerebral cortex: 40 nTPM
- medulla oblongata: 40 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.44
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- blood coagulation
- endothelial cell apoptotic process
- lipid metabolic process
- negative regulation of apoptotic process
- negative regulation of endothelial cell apoptotic process
- negative regulation of fatty acid biosynthetic process
- negative regulation of very-low-density lipoprotein particle remodeling
- positive regulation of angiogenesis
- protein unfolding
- regulation of chylomicron remodeling
- response to hypoxia
- triglyceride homeostasis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANGPTL4 as an antibody target. Whether an autoantibody or antibody against ANGPTL4 could matter depends on whether native ANGPTL4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANGPTL4 is annotated as secreted, so native ANGPTL4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ANGPTL4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...